Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis – Company Announcement - FT.com

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis – Company Announcement - FT.com

Information on 2 May elections

Information on 2 May elections

Fire breaks out next to old Harrow Civic Centre

Fire breaks out next to old Harrow Civic Centre